JP2006520803A5 - - Google Patents

Download PDF

Info

Publication number
JP2006520803A5
JP2006520803A5 JP2006507432A JP2006507432A JP2006520803A5 JP 2006520803 A5 JP2006520803 A5 JP 2006520803A5 JP 2006507432 A JP2006507432 A JP 2006507432A JP 2006507432 A JP2006507432 A JP 2006507432A JP 2006520803 A5 JP2006520803 A5 JP 2006520803A5
Authority
JP
Japan
Prior art keywords
composition
acid
fatty acid
subject
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507432A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006520803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/008650 external-priority patent/WO2004084829A2/en
Publication of JP2006520803A publication Critical patent/JP2006520803A/ja
Publication of JP2006520803A5 publication Critical patent/JP2006520803A5/ja
Pending legal-status Critical Current

Links

JP2006507432A 2003-03-20 2004-03-22 エステル化脂肪酸組成物 Pending JP2006520803A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45586003P 2003-03-20 2003-03-20
PCT/US2004/008650 WO2004084829A2 (en) 2003-03-20 2004-03-22 Esterified fatty acid composition

Publications (2)

Publication Number Publication Date
JP2006520803A JP2006520803A (ja) 2006-09-14
JP2006520803A5 true JP2006520803A5 (enExample) 2007-05-17

Family

ID=33098072

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507432A Pending JP2006520803A (ja) 2003-03-20 2004-03-22 エステル化脂肪酸組成物

Country Status (6)

Country Link
US (1) US7612111B2 (enExample)
EP (1) EP1617830A4 (enExample)
JP (1) JP2006520803A (enExample)
AU (2) AU2004224332A1 (enExample)
CA (1) CA2519278C (enExample)
WO (1) WO2004084829A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776914B2 (en) * 2004-03-22 2010-08-17 Imagenetix, Inc. Esterified fatty acid composition
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
PL2234994T3 (pl) * 2007-12-27 2018-02-28 Cibus Europe B.V. Mieszanki estrów butylowych kwasów tłuszczowych
KR20110007088A (ko) * 2008-01-25 2011-01-21 비 앤드 티 에스.알.엘. 화장품 분야에서의 트랜스에스테르화 올리브 오일의 용도
WO2010005004A1 (ja) * 2008-07-07 2010-01-14 花王株式会社 キサンチンオキシダーゼ阻害剤及び尿酸生成阻害剤
US20120142776A1 (en) * 2009-04-09 2012-06-07 Leinwand Leslie A Methods and compositions for inducing physiological hypertrophy
CA2795907A1 (en) * 2009-04-09 2010-10-14 The Regents Of The University Of Colorado, A Body Corporate Methods and compositions for inducing physiological hypertrophy
CA2792003A1 (en) * 2010-03-02 2011-09-09 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
ES2395539B1 (es) * 2011-06-16 2014-01-20 Agencia Pública Empresarial Sanitaria Hospital Alto Guadalquivir Uso del aceite de oliva en la prevención y el tratamiento de las enfermedades que cursan con un proceso isquémico
ITMI20130354A1 (it) * 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
JP6609850B2 (ja) * 2014-01-24 2019-11-27 国立大学法人京都大学 希少脂肪酸を含む抗炎症剤
AU2016219974A1 (en) * 2015-02-18 2017-09-07 Tersus Life Sciences, LLC Methods for improving joint function
ITUB20153130A1 (it) * 2015-08-14 2017-02-14 Pharmanutra S P A Acidi grassi cetilati, impianto per la loro preparazione e relativo uso
AU2017348410B2 (en) * 2016-10-31 2023-11-02 The Cleveland Clinic Foundation Capric acid and myristic acid compositions for treating conditions
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
US20220146526A1 (en) * 2019-05-09 2022-05-12 Shimadzu Corporation Method for evaluating sample, analysis method, method for detecting degraded sample, marker for detecting degraded blood plasma sample, and marker for detecting degraded serum sample
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900007329A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati per uso nel trattamento della mucosa gastrica, diabete e alti livelli di glicemia
IT201900007311A1 (it) * 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT202300004227A1 (it) 2023-03-07 2024-09-07 Pharmanutra S P A Composizioni comprendenti acidi grassi cetilati e vitamina d, e loro usi relativi

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049824A (en) * 1976-05-03 1977-09-20 Harry Weldon Diehl Cetyl myristoleate
US4330557A (en) * 1979-05-21 1982-05-18 Claudio Cavazza Acyl-carnitine and use thereof in parenteral administration of triglycerides
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
JPS60215624A (ja) * 1984-04-11 1985-10-29 Akira Kitano 消炎鎮痛剤
JPS6172715A (ja) * 1984-09-18 1986-04-14 Kao Corp 外用抗炎症剤
JP2530661B2 (ja) * 1987-07-31 1996-09-04 ピジョン株式会社 乳液状皮膚清拭剤
JPH0423298Y2 (enExample) 1987-08-19 1992-05-29
JPH06247852A (ja) * 1993-02-22 1994-09-06 Sekisui Chem Co Ltd 炎症性皮膚疾患治療用外用剤
US5569676A (en) * 1995-05-24 1996-10-29 Diehl; Harry W. Method for the treatment of osteoarthritis
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
MXPA00010103A (es) * 1998-04-16 2002-08-06 Natural Health Products Intern Metodo para el tratamiento de asma.
US6417227B1 (en) * 1999-04-28 2002-07-09 Cg And Associates Methods of delivery of cetyl myristoleate
GB9927629D0 (en) * 1999-11-24 2000-01-19 Croda Int Plc Compounds
ES2299484T3 (es) * 2000-05-12 2008-06-01 Meracol Corporation Limited Tratamiento del sindrome o enfermedad de intestino irritable.
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation

Similar Documents

Publication Publication Date Title
JP2006520803A5 (enExample)
CA2519278A1 (en) Esterified fatty acid composition
AU618010B2 (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
TW389696B (en) Accelerated release composition containing bromocriptine
AU606149B2 (en) Pharmaceutical formulations
JP2005515966A5 (enExample)
JP2004518653A (ja) 不安障害を治療する方法
AU2015343199A1 (en) Methods of administering amantadine compositions
JP6655625B2 (ja) ピラゾリン由来化合物ならびに哺乳動物における変形性関節疾患に由来する炎症および疼痛に対する週間投与計画におけるその使用
CN102119923A (zh) 一种兽用抗菌油、水双混悬型注射用乳剂及其制备方法
KR102419769B1 (ko) 약물 조성물
JPH08506808A (ja) 呼吸障害治療用組成物の製造における鎮痛剤ｓ（＋）対掌体の利用
JP3982889B2 (ja) イブプロフェン含有医薬製剤
JPH0475205B2 (enExample)
JPH06502428A (ja) デキストロメトルファン鎮咳組成物
MX2011001631A (es) Tratamiento de transtornos de ansiedad.
CN112641805A (zh) 熊胆粉在制备治疗上呼吸道感染药物中的应用
CN1094615A (zh) 提供改进的止痛效果的组合物和方法
CN106924283A (zh) 一种含蒙脱石、药用活性炭的止泻药物组合物及制备方法和用途
CN111888353A (zh) 瑞香素在制备预防和/或治疗增龄所致的肌肉萎缩、肌少症、运动能力衰退的药物中的应用
CN114209815B (zh) 一种药物组合物及其制备方法和应用
JPH02503314A (ja) ヒトの異常脂肪血症治療剤
CN116832057A (zh) 氯化铷在制备治疗帕金森综合征的药物中的用途
US9284281B2 (en) Indication of naphtho[2,3-F]quinoxaline-7,12-dione compound in alleviating pain
CN115804768A (zh) 白花前胡乙素在制备治疗神经退行性疾病药物中的应用